Navigation Links
Biomedical and health professionals converge in D.C. to absorb new findings in science of informatics
Date:11/15/2010

Washington, DC, Nov. 15The 34th Annual Symposium on Biomedical and Health Informatics opened this week with keynote speaker Susan Dentzer, editor in chief of Health Affairs, addressing a crowd of more than two thousand professionals who are central to modernizing the nation's health sector by applying the science of informatics to a variety of specialized health domains, including public health, clinical practice, clinical research, and translational bioinformatics. The informatics work force develops and encourages use of critical decision-support tools for healthcare providers, adopts and promotes use of electronic health records as a tool for collaborative treatment of patients, and creates resources and tools used in biomedical research. The Symposium's theme, Informatics: Key to Quality Care and Scientific Progress, links together 102 scientific sessions, two keynote speakers, 364 scientific posters, 71 exhibits, a number of theatre-style demonstrations, and six late-breaking sessions. Sessions are led by informatics experts in a professional community that spans academia, industry, clinical settings, research environments, and government and nonprofit agencies.

The Department of Health and Human Services' National Coordinator on Health Information Technology, David Blumenthal, MD, addressed the Symposium at a plenary session this morning. He told the audience, "AMIA plays a leading role in the nation's transition to the quality benefits and efficiencies of health information technology, and this year's Symposium promises to continue supporting our movement forward." Dr. Blumenthal's office is responsible for the implementation of a nationwide interoperable, privacy-protected health information technology infrastructure.

In opening the Symposium, Scientific Program Committee Chair Gilad Kuperman, MD, PhD, FACMI, of New York-Presbyterian Hospital and Columbia University, described the challenges informatics professionals face working in today's health sector. "Introducing complex technology into a complex health care system requires a deliberate and thoughtful approach," he said. "Simultaneously, important advances in biomedical computational techniques are helping us understand the best ways to extract meaning from health data, discover new knowledge, support clinical research, and understand how best to use information technology to improve the health of individuals and populations."

A number of Symposium sessions are devoted to examination of how ARRA and the HITECH Act are energizing the field of informatics in key areas: workforce expansion and research. One late-breaking session, for example, takes a close look at the current adequacy of quality measures in the electronic era, and how electronic health records (EHRs) support quality measurement and standardization of quality measurements. Another session, also linked to the ARRA stimulus, includes a panel of ONC grant recipients sharing their initial challenges and lessons learned as they move forward in HIT adoption. The panel members are able to contrast the different operating models, and outreach and technical assistance strategies employed by each of the various Regional Extension Centers established by HITECH grant funds.

A late-breaking session scheduled for Wednesday, Nov. 17, focuses on HIT vendor contracts, their customers, ethical practices, and patient safety. This session provides analysis of AMIA's recently published position on HIT vendors, their customers, and patient safety, including contract language and other elements of the vendor-customer relationship that can be improved upon for more meaningful use of HIT systems in clinical practice settings.

In his remarks to the Symposium, AMIA President and CEO Edward H. Shortliffe, MD, PhD, FACMI, indicated significant growth plans for AMIA and revealed a new logo and tagline. He said that the refreshed branding is meant to convey AMIA's readiness to broaden its scope of activity, opening the association to greater numbers of professionals and students, and overall, wielding greater influence in the future of health care delivery, and the education of healthcare providers, public health workers and officials, computer scientists, policymakers, and others involved in the build-out of a national health system that is both interoperable and standardized.

"In less than 10 years," said Dr. Shortliffe, "most Americans will know the term 'informatics' and will understand that it is the science that underpins their physicians' capacity to make a speedy, precise diagnosis, to prescribe medication remotely, and to read test results, distribute information to other consulting physician groups, and download results and notes to patients. People will begin to expect health data at their fingertips, in much the same way they interact as agents in their personal banking, personal travel, and online investing." This fundamental aspect of transforming the health sector, according to Dr. Shortliffe, was the inspiration for AMIA's new tagline: Informatics Professionals. Leading the Way.


'/>"/>

Contact: Nancy Light
nlight@amia.org
301-275-1203
American Medical Informatics Association
Source:Eurekalert

Related biology news :

1. Supercomputer provides massive computational boost to biomedical research at TGen
2. Biomedical engineers detective work reveals antibiotic mechanism
3. Biomedical research profits from the exploration of the deep sea
4. University of Miami biomedical engineer
5. Biomedical researchers create artificial human bone marrow in a test tube
6. Fluorescent proteins illuminating biomedical research
7. NJIT to host major biomedical engineering showcase and career fair
8. GUMC young scientist selected postdoc Fellow at National Space Biomedical Research Institute
9. Biomedical engineering student recognized as IEEEs New Face of Engineering
10. Biomedical researchers invited to design experiments for the International Space Station
11. Former NASA astronaut Bonnie J. Dunbar to speak at NJITs biomedical engineering seminar
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/3/2016)... , February 4, 2016 --> ... to SEK 1,351.5 M (105.0), up 1,187% compared with fourth quarter of ... amounted to SEK 517.6 M (loss: 30.0). Earnings per share ... activities was SEK 537.4 M (neg: 74.7). , ... , Revenues amounted to SEK 2,900.5 M (233.6), up 1,142% compared with ...
(Date:2/2/2016)... YORK , Feb. 2, 2016 /PRNewswire/ ... facilities are primarily focused on medical screening ... measure point-of-care parameters. Wearable devices that facilitate ... user,s freedom of movement are being bolstered ... for human biomedical signal acquisition coupled with ...
(Date:2/2/2016)... RESTON, Va. , Feb. 2, 2016 /PRNewswire/ ... contract award from the U.S. Army Research Office ... extend the range and sensitivity of the company,s ... DoD,s Past Accounting Mission and, more generally, defense-related ... its DNA phenotyping capabilities (predicting appearance and ancestry ...
Breaking Biology News(10 mins):
(Date:2/8/2016)... Conn. , Feb. 8, 2016  NanoViricides, Inc. (NYSE MKT: ... its CEO, Eugene Seymour , MD, MPH, will present information ... at the Waldorf-Astoria Hotel in New York City ... will be in the Windsor Room at 5:30PM EST. Registered attendees ... New York City . --> ...
(Date:2/8/2016)... -- --> --> ... ultra-rapid Point-Of-Care (POC) molecular diagnostics company, today announces that it ... test to be launched on the Company,s io® platform. By ... test is now cleared for sale within the European Union. ... of the io® CT test signals a new era in ...
(Date:2/5/2016)... 2016 ATCC, the premier global biological materials ... medical and life science researchers that are working to ... CDC website . --> ... is a single-stranded RNA virus of the Flaviviridae family, ... and Chikungunya Viruses. Zika virus is transmitted to humans ...
(Date:2/5/2016)... , February 5, 2016 Amarantus ... biotechnology company focused on developing products for Regenerative Medicine, ... Rare Pediatric Disease Designation (RPDD) from the US Food ... with MANF. MANF was previously granted orphan drug designation ... --> Amarantus BioScience Holdings, Inc. (OTCQB: ...
Breaking Biology Technology: